Hagi K - Search Results

1

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.

Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU. Kishimoto T, et al. Among authors: hagi k. Lancet Psychiatry. 2021 May;8(5):387-404. doi: 10.1016/S2215-0366(21)00039-0. Epub 2021 Apr 13. Lancet Psychiatry. 2021. PMID: 33862018

2

Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis.

Galling B, Garcia MA, Osuchukwu U, Hagi K, Correll CU. Galling B, et al. Among authors: hagi k. Expert Opin Drug Saf. 2015 Aug;14(8):1181-99. doi: 10.1517/14740338.2015.1053457. Epub 2015 Jun 24. Expert Opin Drug Saf. 2015. PMID: 26107820 Review.

3

Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis.

Galling B, Calsina Ferrer A, Abi Zeid Daou M, Sangroula D, Hagi K, Correll CU. Galling B, et al. Among authors: hagi k. Expert Opin Drug Saf. 2015 Oct;14(10):1587-608. doi: 10.1517/14740338.2015.1085970. Epub 2015 Sep 10. Expert Opin Drug Saf. 2015. PMID: 26360500 Review.

4

Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories.

Kishimoto T, Chawla JM, Hagi K, Zarate CA, Kane JM, Bauer M, Correll CU. Kishimoto T, et al. Among authors: hagi k. Psychol Med. 2016 May;46(7):1459-72. doi: 10.1017/S0033291716000064. Epub 2016 Feb 12. Psychol Med. 2016. PMID: 26867988 Free PMC article.

5

Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.

Galling B, Roldán A, Rietschel L, Hagi K, Walyzada F, Zheng W, Cao XL, Xiang YT, Kane JM, Correll CU. Galling B, et al. Among authors: hagi k. Expert Opin Drug Saf. 2016 May;15(5):591-612. doi: 10.1517/14740338.2016.1165668. Epub 2016 Apr 7. Expert Opin Drug Saf. 2016. PMID: 26967126 Review.

6

Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis.

Miura I, Zhang JP, Hagi K, Lencz T, Kane JM, Yabe H, Malhotra AK, Correll CU. Miura I, et al. Among authors: hagi k. Psychoneuroendocrinology. 2016 Oct;72:1-10. doi: 10.1016/j.psyneuen.2016.06.002. Epub 2016 Jun 6. Psychoneuroendocrinology. 2016. PMID: 27333159 Free PMC article. Review.

7

Safety and tolerability of long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled studies comparing the same antipsychotics.

Misawa F, Kishimoto T, Hagi K, Kane JM, Correll CU. Misawa F, et al. Among authors: hagi k. Schizophr Res. 2016 Oct;176(2-3):220-230. doi: 10.1016/j.schres.2016.07.018. Epub 2016 Aug 4. Schizophr Res. 2016. PMID: 27499361 Review.

8

Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis.

Galling B, Roldán A, Hagi K, Rietschel L, Walyzada F, Zheng W, Cao XL, Xiang YT, Zink M, Kane JM, Nielsen J, Leucht S, Correll CU. Galling B, et al. Among authors: hagi k. World Psychiatry. 2017 Feb;16(1):77-89. doi: 10.1002/wps.20387. World Psychiatry. 2017. PMID: 28127934 Free PMC article.

9

Modafinil Treatment of Cocaine Dependence: A Systematic Review and Meta-Analysis.

Sangroula D, Motiwala F, Wagle B, Shah VC, Hagi K, Lippmann S. Sangroula D, et al. Among authors: hagi k. Subst Use Misuse. 2017 Aug 24;52(10):1292-1306. doi: 10.1080/10826084.2016.1276597. Epub 2017 Mar 28. Subst Use Misuse. 2017. PMID: 28350194 Review.

10

Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Kishi T, Matsui Y, Matsuda Y, Katsuki A, Hori H, Yanagimoto H, Sanada K, Morita K, Yoshimura R, Shoji Y, Hagi K, Iwata N. Kishi T, et al. Among authors: hagi k. Pharmacopsychiatry. 2019 Feb;52(2):52-62. doi: 10.1055/a-0574-0088. Epub 2018 Mar 7. Pharmacopsychiatry. 2019. PMID: 29514360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page